CD
GNMX
Carl Domino’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $55K | Hold |
43,273
| – | – | 0.07% | 113 |
|
|
2017
Q2 | $58K | Buy |
43,273
+10,000
| +30% | +$13.4K | 0.07% | 118 |
|
|
2017
Q1 | $62K | Hold |
33,273
| – | – | 0.07% | 120 |
|
|
2016
Q4 | $172K | Hold |
33,273
| – | – | 0.18% | 105 |
|
|
2016
Q3 | $179K | Hold |
33,273
| – | – | 0.17% | 114 |
|
|
2016
Q2 | $185K | Sell |
33,273
-861
| -3% | -$4.79K | 0.17% | 116 |
|
|
2016
Q1 | $150K | Hold |
34,134
| – | – | 0.14% | 128 |
|
|
2015
Q4 | $205K | Hold |
34,134
| – | – | 0.16% | 122 |
|
|
2015
Q3 | $267K | Hold |
34,134
| – | – | 0.21% | 97 |
|
|
2015
Q2 | $209K | Hold |
34,134
| – | – | 0.14% | 132 |
|
|
2015
Q1 | $275K | Sell |
34,134
-3,000
| -8% | -$24.2K | 0.21% | 111 |
|
|
2014
Q4 | $188K | Buy |
37,134
+17,000
| +84% | +$86.1K | 0.1% | 158 |
|
|
2014
Q3 | $104K | Hold |
20,134
| – | – | 0.06% | 168 |
|
|
2014
Q2 | $156K | Hold |
20,134
| – | – | 0.08% | 166 |
|
|
2014
Q1 | $141K | Sell |
20,134
-1,148
| -5% | -$8.04K | 0.07% | 164 |
|
|
2013
Q4 | $127K | Sell |
21,282
-2,846
| -12% | -$17K | 0.07% | 165 |
|
|
2013
Q3 | $188K | Sell |
24,128
-5,850
| -20% | -$45.6K | 0.11% | 149 |
|
|
2013
Q2 | $114K | Buy |
+29,978
| New | +$114K | 0.06% | 154 |
|